Bank of Montreal Can Reduces Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Bank of Montreal Can trimmed its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 27.9% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 291,083 shares of the medical instruments supplier’s stock after selling 112,585 shares during the period. Bank of Montreal Can owned about 0.14% of DENTSPLY SIRONA worth $7,251,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. First Eagle Investment Management LLC raised its position in shares of DENTSPLY SIRONA by 33.6% in the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after buying an additional 3,283,965 shares during the last quarter. Generation Investment Management LLP raised its holdings in DENTSPLY SIRONA by 43.4% in the 4th quarter. Generation Investment Management LLP now owns 6,598,211 shares of the medical instruments supplier’s stock valued at $234,830,000 after acquiring an additional 1,998,012 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of DENTSPLY SIRONA by 21.1% during the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock worth $289,640,000 after purchasing an additional 1,419,503 shares during the last quarter. SG Americas Securities LLC grew its position in shares of DENTSPLY SIRONA by 2,959.1% in the first quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock valued at $45,584,000 after purchasing an additional 1,328,525 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in shares of DENTSPLY SIRONA by 42.0% in the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after purchasing an additional 1,308,411 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Up 0.0 %

Shares of XRAY opened at $27.06 on Tuesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87. DENTSPLY SIRONA Inc. has a 12 month low of $23.58 and a 12 month high of $37.60. The stock has a market cap of $5.62 billion, a PE ratio of -61.50, a P/E/G ratio of 1.30 and a beta of 1.00. The stock’s 50-day moving average is $25.54 and its two-hundred day moving average is $27.56.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The company had revenue of $984.00 million during the quarter, compared to analysts’ expectations of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm’s revenue was down 4.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.51 EPS. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.37%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on XRAY. Robert W. Baird decreased their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Barrington Research restated an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Needham & Company LLC reiterated a “buy” rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Finally, Stifel Nicolaus dropped their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and a consensus target price of $33.22.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.